Vaxcyte, Inc. (PCVX)
NASDAQ: PCVX · Real-Time Price · USD
31.65
+0.39 (1.25%)
Aug 21, 2025, 1:49 PM - Market open

Vaxcyte Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2024FY 2023FY 2022FY 2021FY 20202018 - 2020
Period Ending
Aug '25 Dec '24 Dec '23 Dec '22 Dec '21 Dec '20 2018 - 2020
4,10910,2035,9763,7871,2561,354
Upgrade
Market Cap Growth
-48.95%70.74%57.79%201.58%-7.24%-
Upgrade
Enterprise Value
2,4928,0504,7243,445978957
Upgrade
Last Close Price
31.2681.8662.8047.9523.7926.57
Upgrade
PB Ratio
1.323.094.823.974.423.91
Upgrade
P/TBV Ratio
1.323.094.823.974.423.91
Upgrade
Debt / Equity Ratio
0.030.020.020.020.06-
Upgrade
Quick Ratio
10.7612.617.4623.088.618.25
Upgrade
Current Ratio
11.1112.767.5423.268.938.30
Upgrade
Return on Equity (ROE)
-21.65%-20.41%-36.67%-36.12%-31.78%-44.58%
Upgrade
Return on Assets (ROA)
-16.44%-14.47%-24.23%-21.82%-18.07%-24.42%
Upgrade
Return on Capital (ROIC)
-17.15%-15.32%-26.10%-22.82%-20.04%-27.97%
Upgrade
Earnings Yield
-13.46%-4.55%-6.73%-5.90%-7.97%-6.59%
Upgrade
FCF Yield
-13.87%-5.60%-6.10%-4.66%-10.19%-3.53%
Upgrade
Buyback Yield / Dilution
-22.51%-25.57%-49.75%-24.95%-75.73%-678.53%
Upgrade
Updated May 7, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.
SEC Filings: 10-K · 10-Q